Cardioversion - mortality
Mortality benefit in cardioverted patients with new-onset AFib
A professor of cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on Wondr Medical. Dan Atar speaks about clinical cardiology topics, covering areas such as acute coronary syndromes, heart failure, atrial fibrillation, and secondary prevention. Further, he has a particular interest in pharmacotherapy.
Mortality benefit in cardioverted patients with new-onset AFib
Changing antithrombotic strategies in ACS+AF
Guidelines and case-examples regarding the current updates on CV prevention.
We use cookies and similar technologies to help personalise content, tailor and measure ads, provide a better experience and employ usual technical measures to prevent unauthorised access to your data on our servers.
Select Accept to consent to this use or Learn more and adjust to make your cookie choices. You can change your cookie choices and withdraw your consent in your settings at any time.
Finally, we will never sell or provide your personal data to third parties without your consent, other than required by law.